Global Butterfly Needle Sets Market: Opportunity Analysis & Industry Forecast, 2020 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Butterfly Needle Sets Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

The global butterfly needle blood collection set market was $166.60 million in 2019, and is expected to reach $320.02 million by 2027, registering a CAGR 8.20% from 2020 to 2027. A butterfly needle is a device used to provide access to superficial vein for drawing blood or for an IV injection. These needles are much easier to use and is less painful due to winged tubing structure that allows greater flexibility. In addition, butterfly needles, also known as a winged infusion set or a scalp vein set, are commonly used for babies, young children, and elderly to draw blood or to administer medication. The needles are short and straight with plastic wings attached for phlebotomists to hold during insertion and ease operation. In addition, winged-infusion blood collection needles are ideal for individuals with small or fragile veins. Further, the common butterfly needles, which are frequently used ranges from gauges, with 21 and 23 gauge (G) and the smallest gauge i.e., 25-27G, are being used primarily for pediatric patients.

The major factors that drive market growth are rise in the prevalence of chronic diseases globally such as cancer, intravenous therapy, cardiovascular diseases, and bleeding disorders. In addition, an increase in the prevalence of chronic diseases and need for managing long term medications and drug infusions are some of the other factors that boost the growth of the market. However, lack of product innovations and regulatory standards on butterfly needle usage and phlebotomists blood collection hamper market growth. Moreover, safety and convenience provided by the needles d treatment associated with butterfly needle offer opportunities for market growth during the forecast period.

KEY BENEFITS FOR STAKEHOLDERS

• The market estimations in this report are based on high-end analysis of the key segments from 2019 to 2027.
• Extensive analysis of the global butterfly needle blood collection set market, by application, helps in understanding various types of techniques of butterfly needles.
• This report provides comprehensive analysis of factors that drive and restrict growth of the butterfly needle blood collection set market.
• Porter's Five Forces model provides an in-depth analysis of the bargaining power of buyers and suppliers, threats of new entrants, substitutes, and competition among the key market players.
• Competitive intelligence highlights the business practices adopted by leading market players across various regions.

Key Topics Covered:

Chapter 1: Introduction

1.1. Report Description

1.2. Key Benefits

1.3. Key Market Segments

1.4. Research Methodology

1.4.1. Primary Research

1.4.2. Secondary Research

1.4.3. Analyst Tools and Models

Chapter 2: Executive Summary

2.1. Key Findings of the Study:

2.2. CXO Perspective

Chapter 3: Market Overview

3.1. Key Findings

3.1.1. Top Investment Pockets

3.2. Porter'sFive Forces Analysis

3.3. Market Definition and Scope

3.3.1. Impact Analysis

3.3.2. Drivers

3.3.3. Restraints

3.3.4. Opportunities

Chapter 4: Butterfly Needle Blood Collection Set Market, by Application

4.1. Overview

4.2. Blood Transfusion

4.3. Venipuncture

4.4. Iv Rehydration

4.5. Delivery of Medications

Chapter 5: Butterfly Needle Blood Collection Set Market, by End-user

5.1. Overview

5.2. Hospital

5.3. Blood Bank

5.4. Others

Chapter 6: Butterfly Needle Blood Collection Set Market, by Region

6.1. Overview

6.2. North America

6.3. Europe

6.4. Asia-Pacific

6.5. LAMEA

Chapter 7: Comapany Profiles

7.1. B. Braun Melsungen AG

7.2. Becton, Dickinson and Company

7.3. Nipro Corporation (Nipro Medical Corporation)

7.4. Cardinal Health Inc.

7.5. Medline Industries, Inc.

7.6. Terumo Corporation (Terumo Medical Corporation)

7.7. Kawasumi Laboratories, Inc. (Kawasumi Laboratories America, Inc.)

7.8. Isomed

7.9. Biomatrix S. R. L.

7.10. Smith'S Group plc

For more information about this report visit https://www.researchandmarkets.com/r/t2opyh